MarketPeel
Insider Trading Intelligence
Pricing
…
HW

Hans Lennart Rudolf Wigzell

SRPT
DIRECTOR · SAREPTA THERAPEUTICS, INC. · CIK 0001492766
FILING MIX · LIFETIME49%/51%
BUYS
19
SELLS
20
TOTAL VALUE
$10.10M
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
42,098
AVG SELL PX
$120.90
TRADE KIND
SHOWING 39 / 39
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
12 backtested trades · 8 horizons · 1 pending
Forward-return performance of every backtestable P/S trade by Hans Lennart Rudolf Wigzell, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d12+58.33%-0.11%-0.32%+0.21%-0.88%—
14d12+58.33%-3.50%+0.31%-3.81%-4.32%—
30d12+33.33%-1.01%+0.40%-1.41%-0.06%—
60d12+41.67%+3.92%+3.17%+0.76%+5.12%—
90d12+66.67%-5.38%+5.82%-11.20%-10.38%—
180d12+58.33%-9.26%+14.09%-23.35%-26.39%—
1y12+91.67%-30.70%+25.31%-56.00%-68.82%—
2y12(1 pending)+90.91%-46.04%+32.88%-78.92%-87.70%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SRPT · 42,098 shares · as of Jun 4, 2026
010,52521,04931,57442,098202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 19 buys / 20 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
16,875——42,098Jun 4, 2026Jun 5, 2026 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,792——4,792Mar 10, 2025Mar 11, 2025 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,383——25,223Mar 10, 2025Mar 11, 2025 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
10,500——0Dec 12, 2024Dec 16, 2024 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASE
10,500$13.71$144.0K33,340Dec 12, 2024Dec 16, 2024 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
10,500$124.84$1.31M22,840Dec 12, 2024Dec 16, 2024 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
11,745$123.10$1.45M22,940Mar 8, 2024Mar 11, 2024 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
3,155$123.85$390.7K34,685Mar 8, 2024Mar 11, 2024 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
100$122.39$12.2K22,840Mar 8, 2024Mar 11, 2024 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
15,000——0Mar 8, 2024Mar 11, 2024 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASE
15,000$13.90$208.5K37,840Mar 8, 2024Mar 11, 2024 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,846——22,840Mar 1, 2024Mar 5, 2024 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
3,679——3,679Mar 1, 2024Mar 5, 2024 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
15,000$106.72$1.60M20,994Aug 4, 2023Aug 8, 2023 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASE
15,000$29.03$435.4K35,994Aug 4, 2023Aug 8, 2023 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
15,000——0Aug 4, 2023Aug 8, 2023 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,523——20,994Mar 6, 2023Mar 8, 2023 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,257——3,257Mar 6, 2023Mar 8, 2023 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,953——19,471Mar 7, 2022Mar 8, 2022 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,077——5,077Mar 7, 2022Mar 8, 2022 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
10,000$83.51$835.1K16,518Mar 8, 2021Mar 10, 2021 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASE
10,000$34.92$349.2K26,518Mar 8, 2021Mar 10, 2021 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
10,000——0Mar 8, 2021Mar 10, 2021 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,726——16,518Mar 3, 2021Mar 5, 2021 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,518——5,518Mar 3, 2021Mar 5, 2021 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
777$159.65$124.0K13,792Aug 10, 2020Aug 11, 2020 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASE
10,000$34.92$349.2K23,792Aug 10, 2020Aug 11, 2020 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
9,223$158.95$1.47M14,569Aug 10, 2020Aug 11, 2020 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
10,000——10,000Aug 10, 2020Aug 11, 2020 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASE
5,000$10.08$50.4K18,792May 20, 2020May 22, 2020 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
2,100$149.62$314.2K16,692May 20, 2020May 22, 2020 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
5,000——0May 20, 2020May 22, 2020 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
854$151.77$129.6K13,792May 20, 2020May 22, 2020 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
2,046$151.22$309.4K14,646May 20, 2020May 22, 2020 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
5,000——0Mar 4, 2020Mar 6, 2020 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASE
5,000$8.46$42.3K18,792Mar 4, 2020Mar 6, 2020 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
SALE
5,000$116.89$584.5K13,792Mar 4, 2020Mar 6, 2020 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,075——13,792Feb 28, 2020Feb 28, 2020 ↗View →
SRPT
SAREPTA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,685——3,685Feb 28, 2020Feb 28, 2020 ↗View →
Other insiders · SRPT
Loading peer insiders…
About this filer
CIK 0001492766
ROLE
Director
PRIMARY
SRPT
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001492766DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback